X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1096) 1096
Publication (56) 56
Book Review (6) 6
Magazine Article (4) 4
Book Chapter (2) 2
Conference Proceeding (2) 2
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1041) 1041
nephrosis, lipoid - pathology (682) 682
male (671) 671
female (630) 630
adult (438) 438
urology & nephrology (381) 381
child (365) 365
middle aged (334) 334
biopsy (328) 328
adolescent (322) 322
kidney - pathology (307) 307
nephrotic syndrome (273) 273
kidney glomerulus - pathology (247) 247
child, preschool (245) 245
index medicus (245) 245
nephrosis, lipoid - drug therapy (221) 221
nephrotic syndrome - pathology (203) 203
aged (191) 191
glomerulosclerosis, focal segmental - pathology (185) 185
nephrosis, lipoid - complications (180) 180
glomerulonephritis - pathology (178) 178
nephrosis, lipoid - diagnosis (169) 169
microscopy, electron (149) 149
nephrosis, lipoid - etiology (129) 129
infant (126) 126
nephrosis, lipoid - metabolism (122) 122
animals (120) 120
minimal change disease (120) 120
glomerulonephritis (116) 116
proteinuria (114) 114
children (112) 112
nephrosis, lipoid - immunology (109) 109
focal segmental glomerulosclerosis (108) 108
retrospective studies (108) 108
nephrology (104) 104
pediatrics (102) 102
prognosis (96) 96
kidney glomerulus - ultrastructure (95) 95
nephrotic syndrome - etiology (90) 90
glomerulonephritis, iga - pathology (88) 88
diagnosis, differential (84) 84
nephrotic syndrome - drug therapy (82) 82
rats (81) 81
glomerulonephritis, membranous - pathology (80) 80
recurrence (80) 80
fluorescent antibody technique (79) 79
disease (77) 77
nephrosis, lipoid - physiopathology (77) 77
pathology (77) 77
young adult (76) 76
nephrosis, lipoid - chemically induced (72) 72
kidney diseases (66) 66
medicine, general & internal (66) 66
time factors (66) 66
nephrotic syndrome - diagnosis (65) 65
treatment outcome (63) 63
immunosuppressive agents - therapeutic use (62) 62
minimal change nephrotic syndrome (61) 61
nephropathy (61) 61
immunohistochemistry (60) 60
nephrosis, lipoid - epidemiology (60) 60
expression (59) 59
follow-up studies (59) 59
proteinuria - etiology (59) 59
kidney diseases - pathology (58) 58
kidney glomerulus - metabolism (56) 56
transplantation (56) 56
medicine & public health (54) 54
prednisone - therapeutic use (54) 54
proteinuria - pathology (54) 54
prednisolone - therapeutic use (53) 53
glomerulosclerosis, focal segmental - diagnosis (52) 52
iga nephropathy (51) 51
glomerular mesangium - pathology (50) 50
glomerulonephritis - immunology (50) 50
glomerulonephritis, membranoproliferative - pathology (50) 50
remission induction (50) 50
nephrosis, lipoid - genetics (49) 49
glomerulosclerosis, focal segmental - drug therapy (47) 47
glomerulosclerosis, focal segmental - metabolism (46) 46
kidney (46) 46
diagnosis (45) 45
glucocorticoids - therapeutic use (45) 45
change nephrotic syndrome (44) 44
disease progression (44) 44
nephrosis, lipoid - blood (42) 42
nephrosis, lipoid - urine (42) 42
glomerulonephritis - diagnosis (41) 41
membranous nephropathy (41) 41
nephrosis, lipoid (41) 41
nephrotic syndrome - complications (40) 40
risk factors (39) 39
steroids - therapeutic use (39) 39
medicine (38) 38
adrenal cortex hormones - therapeutic use (37) 37
nephrosis, lipoid - therapy (37) 37
renal biopsy (36) 36
research (36) 36
analysis (35) 35
creatinine - blood (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (934) 934
Japanese (50) 50
Russian (26) 26
German (25) 25
Spanish (24) 24
French (23) 23
Chinese (21) 21
Italian (10) 10
Polish (5) 5
Bulgarian (4) 4
Danish (3) 3
Dutch (3) 3
Czech (2) 2
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 04/2013, Volume 83, Issue 4, pp. 749 - 756
The Nephrotic Syndrome Study Network (NEPTUNE) is a North American multicenter collaborative consortium established to develop a translational research... 
clinical trial | focal segmental glomerulosclerosis | membranous nephropathy | nephrotic syndrome | CLINICAL SPECTRUM | BIOLOGY | UROLOGY & NEPHROLOGY | GENETIC-HETEROGENEITY | CLASSIFICATION | RENAL-DISEASE | IDIOPATHIC MEMBRANOUS NEPHROPATHY | Predictive Value of Tests | Glomerulonephritis - therapy | Prognosis | Prospective Studies | Age Factors | Glomerulosclerosis, Focal Segmental - genetics | Humans | Nephrosis, Lipoid - epidemiology | Glomerulonephritis, Membranous - genetics | Glomerulonephritis, Membranous - epidemiology | Nephrotic Syndrome - genetics | Systems Biology | Time Factors | Adult | Registries | Surveys and Questionnaires | Nephrotic Syndrome - therapy | Translational Medical Research - methods | Child | Glomerulonephritis, Membranous - therapy | Glomerulonephritis - epidemiology | Glomerulosclerosis, Focal Segmental - epidemiology | Glomerulonephritis, Membranous - pathology | Risk Factors | Glomerulonephritis - genetics | Cooperative Behavior | Nephrotic Syndrome - pathology | Genotype | Nephrosis, Lipoid - therapy | Nephrosis, Lipoid - genetics | Phenotype | Pilot Projects | Nephrosis, Lipoid - pathology | Biopsy | Glomerulonephritis - pathology | Nephrotic Syndrome - epidemiology | Glomerulosclerosis, Focal Segmental - therapy | North America - epidemiology | Longitudinal Studies | Research Design | Glomerulosclerosis, Focal Segmental - pathology
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2017, Volume 12, Issue 4, pp. 614 - 623
Background and objectives Large-scale, contemporary studies exploring glomerular disease epidemiology in the United States are lacking. We aimed to determine... 
Glomerulonephritis | Demography | Humans | Middle Aged | Hispanic Americans | African Americans | Antibodies | Male | Lupus nephritis | Nephrosis | Histopathology | Renal biopsy | Glomerular disease | Adult | Lipoid | Cross-Sectional Studies | Diabetic Nephropathies | MeSH Browser: Southeastern United States Southeastern United States | European Continental Ancestry Group | Environmental Exposure | Clinical epidemiology | Biopsy | Aged | Antineutrophil Cytoplasmic | Kidney Glomerulus | GLOMERULONEPHRITIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CHANGING INCIDENCE | ADULTS | UROLOGY & NEPHROLOGY | IGA NEPHROPATHY | CLASSIFICATION | PREVALENCE | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | RENAL BIOPSY | Nephrosis, Lipoid - epidemiology | Child, Preschool | Infant | Glomerulonephritis, Membranous - epidemiology | Incidence | Young Adult | Time Factors | Female | Lupus Nephritis - epidemiology | Child | Glomerulonephritis, IGA - epidemiology | Glomerulonephritis - epidemiology | Glomerulonephritis, IGA - pathology | Lupus Nephritis - pathology | Glomerulonephritis, Membranoproliferative - pathology | Diabetic Nephropathies - pathology | Glomerulosclerosis, Focal Segmental - epidemiology | Glomerulonephritis, Membranous - pathology | Southeastern United States - epidemiology | Kidney Glomerulus - pathology | Nephrosis, Lipoid - pathology | Glomerulonephritis - pathology | Adolescent | Diabetic Nephropathies - epidemiology | Glomerulonephritis, Membranoproliferative - epidemiology | Glomerulosclerosis, Focal Segmental - pathology | renal biopsy | histopathology | glomerular disease | Antibodies, Antineutrophil Cytoplasmic | clinical epidemiology | lupus nephritis | Nephrosis, Lipoid | glomerulonephritis | Original
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 03/2015, Volume 87, Issue 3, pp. 564 - 574
Journal Article
Pediatrics, ISSN 0031-4005, 08/2009, Volume 124, Issue 2, pp. 747 - 757
The therapeutic approach to childhood nephrotic syndrome is based on a series of studies that began with an international collaborative effort sponsored by the... 
Kidney disease | Nephrosis | Pediatric | Proteinuria | LONG-TERM | MINIMAL CHANGE | STEROID-RESISTANT | proteinuria | kidney disease | INITIAL TREATMENT | VARICELLA VACCINATION | pediatric | PREDNISOLONE THERAPY | CYCLOSPORINE THERAPY | PEDIATRICS | nephrosis | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | INDUCED OBESITY | THROMBOEMBOLIC COMPLICATIONS | Glucocorticoids - therapeutic use | Kidney - pathology | Humans | Immunosuppressive Agents - therapeutic use | Antineoplastic Agents - therapeutic use | Nephrotic Syndrome - drug therapy | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Kidney Function Tests | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Nephrosis, Lipoid - drug therapy | Drug Therapy, Combination | Child | Nephrotic Syndrome - diagnosis | Drug Resistance | Glucocorticoids - adverse effects | Nephrosis, Lipoid - diagnosis | Prednisone - adverse effects | Drug Administration Schedule | Nephrotic Syndrome - pathology | Combined Modality Therapy | Cyclosporine - therapeutic use | Mycophenolic Acid - adverse effects | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Nephrosis, Lipoid - pathology | Biopsy | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Nephrosis, Lipoid - classification | Nephrotic Syndrome - classification | Prednisone - therapeutic use | Care and treatment | Demographic aspects | Nephrotic syndrome | Research | Children | Diseases | Pediatrics | Nephrology | Disease management | Kidney diseases | Children & youth | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 2013, Volume 24, Issue 12, pp. 2081 - 2095
Journal Article
Kidney International, ISSN 0085-2538, 12/2011, Volume 80, Issue 12, pp. 1328 - 1338
The mechanism of selective albuminuria in minimal change nephrotic syndrome, in which glomerular capillaries are diffusely covered by effaced podocyte foot... 
glomerular filtration barrier | NADPH oxidase | nephrotic syndrome | podocyte | reactive oxygen species | nephritic syndrome | AMINONUCLEOSIDE NEPHROSIS | GLOMERULAR-BASEMENT-MEMBRANE | PERMEABILITY | SLIT DIAPHRAGM | NEPHRIN | DIABETIC-NEPHROPATHY | MASSIVE PROTEINURIA | FILTRATION BARRIER | UROLOGY & NEPHROLOGY | KIDNEY | PROXIMAL TUBULE | Immunohistochemistry | Immunoprecipitation | Reactive Oxygen Species - metabolism | Humans | Receptors, Fc - metabolism | NADPH Oxidases - metabolism | Podocytes - enzymology | Rats, Inbred Lew | Nephrosis, Lipoid - enzymology | Nephrosis, Lipoid - urine | Male | Green Fluorescent Proteins - genetics | Puromycin | Histocompatibility Antigens Class I - metabolism | Biological Transport | Acetophenones - pharmacology | Nephrosis, Lipoid - drug therapy | Albuminuria - urine | Disease Models, Animal | Albuminuria - pathology | Green Fluorescent Proteins - metabolism | Microscopy, Electron, Transmission | Microscopy, Electron, Scanning | Rats, Transgenic | Endocytosis - drug effects | NADPH Oxidases - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Rats | Albuminuria - prevention & control | Rats, Sprague-Dawley | Albuminuria - enzymology | Microscopy, Confocal | Podocytes - ultrastructure | Animals | Nephrosis, Lipoid - pathology | Podocytes - drug effects | Albuminuria - chemically induced | Nephrosis, Lipoid - chemically induced | Kinetics | Oxidative Stress - drug effects | Serum Albumin - metabolism
Journal Article
PLOS ONE, ISSN 1932-6203, 06/2019, Volume 14, Issue 6, p. e0217569
There are controversies whether Minimal Change Disease (MCD) and Focal and Segmental Glomerulosclerosis (FSGS) are distinct glomerular lesions or different... 
MINIMAL CHANGE DISEASE | PLASMINOGEN-ACTIVATOR | MULTIDISCIPLINARY SCIENCES | SOLUBLE UROKINASE RECEPTOR | PROTEINURIA | CHANGE NEPHROTIC SYNDROME | NPHS2 PODOCIN | MUTATIONS | KIDNEY | EXPRESSION | PODOCYTES | Predictive Value of Tests | WT1 Proteins - metabolism | Glomerulosclerosis, Focal Segmental - genetics | Humans | Child, Preschool | Male | Intracellular Signaling Peptides and Proteins - metabolism | Case-Control Studies | Autopsy | Kidney Glomerulus - metabolism | Female | Membrane Proteins - metabolism | Child | Intracellular Signaling Peptides and Proteins - genetics | WT1 Proteins - genetics | Nephrosis, Lipoid - metabolism | Biomarkers - metabolism | Diagnosis, Differential | Gene Expression | Nephrosis, Lipoid - diagnosis | Membrane Proteins - genetics | Kidney Glomerulus - pathology | Nephrosis, Lipoid - genetics | Glomerulosclerosis, Focal Segmental - metabolism | Glomerulosclerosis, Focal Segmental - diagnosis | Receptors, Urokinase Plasminogen Activator - metabolism | Nephrosis, Lipoid - pathology | Biopsy | Adolescent | Receptors, Urokinase Plasminogen Activator - genetics | Glomerulosclerosis, Focal Segmental - pathology | Usage | Kidneys | Analysis | Kidney diseases | Diagnosis | Research | Methods | Membrane proteins | Pediatrics | Autopsies | Renal function | Transplants & implants | Disease | Sclerosis | Cell adhesion & migration | U-Plasminogen activator | Proteins | Pathology | Urokinase | Sensitivity | Biomarkers | Bioindicators | Diagnostic systems | Diaphragm | Lesions | Discipline
Journal Article
Journal Article
by Mariani, Laura H and Bomback, Andrew S and Canetta, Pietro A and Flessner, Michael F and Helmuth, Margaret and Hladunewich, Michelle A and Hogan, Jonathan J and Kiryluk, Krzysztof and Nachman, Patrick H and Nast, Cynthia C and Rheault, Michelle N and Rizk, Dana V and Trachtman, Howard and Wenderfer, Scott E and Bowers, Corinna and Hill-Callahan, Peg and Marasa, Maddalena and Poulton, Caroline J and Revell, Adelaide and Vento, Suzanne and Barisoni, Laura and Cattran, Dan and D’Agati, Vivette and Jennette, J. Charles and Klein, Jon B and Laurin, Louis-Philippe and Twombley, Katherine and Falk, Ronald J and Gharavi, Ali G and Gillespie, Brenda W and Gipson, Debbie S and Greenbaum, Larry A and Holzman, Lawrence B and Kretzler, Matthias and Robinson, Bruce and Smoyer, William E and Guay-Woodford, Lisa M and Ahn, Wooin and Appel, Gerald B and Babayev, Revekka and Batal, Ibrahim and Bomback, Andrew S and Brown, Eric and Campenot, Eric S and Canetta, Pietro and Carlassara, Lucrezia and Chan, Brenda and Chatterjee, Debanjana and D’Agati, Vivette D and Delbarba, Elisa and Dogra, Samriti and Fernandez, Hilda and Foroncewicz, Bartosz and Gharavi, Ali G and Ghiggeri, Gian Marco and Hines, William H and Ali Husain, S and Jain, Namrata G and Khairallah, Pascale and Kil, Byum Hee and Kiryluk, Krzysztof and Jeyabalan, Anushya and Lau, Wai L and Lin, Fangming and Lugani, Francesca and Marasa, Maddalena and Markowitz, Glen and Mohan, Sumit and Mu, Xueru and Mucha, Krzysztof and Nickolas, Thomas L and Piva, Stacy and Radhakrishnan, Jai and Rao, Maya K and Regunathan-Shenk, Renu and Sanna-Cherchi, Simone and Santoriello, Dominick and Shirazian, Shayan and Stokes, Michael B and Yu, Natalie and Valeri, Anthony M and Zviti, Ronald and Greenbaum, Larry A and Smoyer, William E and Al-Uzri, Amira and Ambruzs, Josephine and Ashoor, Isa and Aviles, Diego and Baracco, Rossana and Barcia, John and Bartosh, Sharon and Belsha, Craig and Bowers, Corinna and Braun, Michael C and Cai, Yi and Chernitskiy, Vladimir and Chishti, Aftab and Claes, Donna and Clark, Kira and Cramer, Carl and ... and CureGN Consortium
American Journal of Kidney Diseases, ISSN 0272-6386, 02/2019, Volume 73, Issue 2, pp. 218 - 229
Glomerular diseases, including minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and immunoglobulin A (IgA) nephropathy,... 
patient-reported outcome (PRO) | kidney biopsy | IgA nephropathy (IgAN) | IgA vasculitis (IgAV) | study design | longitudinal cohort | pediatric | membranous nephropathy (MN) | glomerulonephropathy | minimal change disease (MCD) | focal segmental glomerulosclerosis (FSGS) | CureGN | Glomerular disease | estimated glomerular filtration rate (eGFR) | Henoch-Schönlein purpura | digital pathology repository | adult | KIDNEY-DISEASE | STEROID-RESISTANT | DIGITAL PATHOLOGY | CLINICAL-TRIALS | UROLOGY & NEPHROLOGY | MEMBRANOUS NEPHROPATHY | IGA NEPHROPATHY | NEPHROTIC SYNDROME | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | RENAL SURVIVAL | CHILDREN | Immunohistochemistry | Nephrosis, Lipoid - mortality | Multivariate Analysis | Glomerulonephritis - therapy | Prognosis | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Young Adult | Adult | Female | Child | Glomerulonephritis, Membranous - therapy | Glomerulonephritis, IGA - pathology | Severity of Illness Index | Diagnosis, Differential | Risk Assessment | Glomerulonephritis, Membranous - pathology | Glomerulonephritis - mortality | Linear Models | Glomerulonephritis, IGA - mortality | Nephrosis, Lipoid - therapy | Academic Medical Centers | Disease Progression | Glomerulonephritis, IGA - therapy | Glomerulosclerosis, Focal Segmental - mortality | Glomerulonephritis, Membranous - mortality | Kidney Failure, Chronic - prevention & control | Nephrosis, Lipoid - pathology | Glomerulonephritis - pathology | Adolescent | Sex Factors | Survival Analysis | Glomerulosclerosis, Focal Segmental - therapy | Biopsy, Needle | Glomerulosclerosis, Focal Segmental - pathology | IgA Vasculitis (IgAV) | Glomerular Disease | Minimal Change Disease (MCD) | Membranous Nephropathy (MN) | Glomerulonephropathy | IgA Nephropathy (IgAN) | Focal Segmental Glomerulosclerosis (FSGS)
Journal Article